Next Article in Journal
The Efficient Antiviral Response of A549 Cells Is Enhanced When Mitochondrial Respiration Is Promoted
Next Article in Special Issue
Phylogenetic Inference of the 2022 Highly Pathogenic H7N3 Avian Influenza Outbreak in Northern Mexico
Previous Article in Journal
Fungal Rhinosinusitis Caused by a Curvularia sp. Infection in a Female Sumatran Orangutan: A Case Report
Previous Article in Special Issue
Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece Respirators
 
 
pathogens-logo
Article Menu

Article Menu

Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Serological Evidence of Orthopoxvirus Infection in Neotropical Primates in Brazil

by
Filipe Vieira Santos de Abreu
1,†,
Kamila Lorene Soares Rocha
2,†,
Ramon Silva-Oliveira
1,
Mariana Viana Macedo
3,
Thamires Gabriele Macedo Silva
3,
Maria Eduarda Gonçalves-dos-Santos
1,
Cirilo Henrique de Oliveira
1,
Sandy Micaele Aquino-Teixeira
1,
Vinícius de Oliveira Ottone
3,
Alex Junio Jardim da Silva
1,
Ronaldo Medeiros dos Santos
1,
Aline Tátila-Ferreira
1,
Marco Antônio Barreto de Almeida
4,
Edmilson dos Santos
4,
Jáder da Cruz Cardoso
4,
Aline Alves Scarpellini Campos
4,
George Rego Albuquerque
5,
Anaiá da Paixão Sevá
5,
Bergmann Morais Ribeiro
6,
Danilo Simonini Teixeira
5,
Fabrício Souza Campos
7,8,
Ana Cláudia Franco
8,
Paulo Michel Roehe
8,
Giliane de Souza Trindade
2,* and
Danilo Bretas de Oliveira
3,*
add Show full author list remove Hide full author list
1
Insect Behavior Laboratory, Instituto Federal do Norte de Minas Gerais, Salinas 39560-000, Minas Gerais, Brazil
2
Laboratório de Vírus, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil
3
Medical School, Health Science Post-Graduate Program, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina 39100-000, Minas Gerais, Brazil
4
Centro Estadual de Vigilância em Saúde, Secretaria de Saúde do Rio Grande do Sul, Porto Alegre 90450-190, Rio Grande do Sul, Brazil
5
Department of Agricultural and Environmental Sciences, State University of Santa Cruz, Ilhéus 45662-900, Bahia, Brazil
6
Cell Biology Department, Biology Institute, Universidade de Brasília, Brasília 70910-000, Brazil
7
Laboratory of Bioinformatics and Biotechnology, Universidade Federal de Tocantins, Gurupi 77402-970, Tocantins, Brazil
8
Laboratório de Virologia—Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal do Rio Grande do Sul, Porto Alegre 90050-170, Rio Grande do Sul, Brazil
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Pathogens 2022, 11(10), 1167; https://doi.org/10.3390/pathogens11101167
Submission received: 26 August 2022 / Revised: 6 October 2022 / Accepted: 7 October 2022 / Published: 10 October 2022

Abstract

:
The genus Orthopoxvirus (OPXV) of the family Poxviridae comprises several viruses that are capable of infecting a wide range of hosts. One of the most widespread OPXVs is the Vaccinia virus (VACV), which circulates in zoonotic cycles in South America, especially in Brazil, infecting domestic and wild animals and humans and causing economic losses as well as impacting public health. Despite this, little is known about the presence and/or exposure of neotropical primates to orthopoxviruses in the country. In this study, we report the results of a search for evidence of OPVX infections in neotropical free-living primates in the state of Minas Gerais, southeast Brazil. The sera or liver tissues of 63 neotropical primates were examined through plaque reduction neutralization tests (PRNT) and real-time PCR. OPXV-specific neutralizing antibodies were detected in two sera (4.5%) from Callithrix penicillata, showing 55% and 85% reduction in plaque counts, evidencing their previous exposure to the virus. Both individuals were collected in urban areas. All real-time PCR assays were negative. This is the first time that evidence of OPXV exposure has been detected in C. penicillata, a species that usually lives at the interface between cities and forests, increasing risks of zoonotic transmissions through spillover/spillback events. In this way, studies on the circulation of OPXV in neotropical free-living primates are necessary, especially now, with the monkeypox virus being detected in new regions of the planet.

1. Introduction

The genus Orthopoxvirus (OPXV) of sub-family Chordopoxvirinae, family Poxviridae, comprises several viruses that are capable of infecting a wide range of hosts. The viruses belonging to this genus are highly complex and share several similarities. This is epidemiologically important since the OPXVs can confer cross-immunity to each other. One of the most widespread OPXVs is the vaccinia virus (VACV), the prototype of the genus Orthopoxvirus, which circulates in zoonotic cycles and infects the cattle and workers in rural areas of Brazil, causing economic losses and impacting public health [1,2].
Since the beginning of the 21st century, VACV has been detected throughout Brazilian territories and has also been found in free-living animals such as rodents, marsupials, procyonids and non-human primates in the Amazon region [3,4], which has increased concerns about wildlife health and sporadic human spillovers, as illustrated by the recent monkeypox outbreak [5,6]. Despite this, little is known about the presence and/or exposure of neotropical primates to the VACV in other regions of Brazil. Therefore, this is the first report of a sampling effort to detect serological and virological evidence of VACV/OPXV infections in neotropical free-living primates in Minas Gerais, which is a region in Brazil that is considered to be the epicenter of VACV outbreaks involving livestock and humans [7,8].

2. Materials and Methods

2.1. Sampling Effort

Samples from neotropical primates were collected between July 2020 and January 2022 from 13 municipalities spread across the northern region of Minas Gerais, Brazil (Figure 1, Table 1). The area is predominantly within the Cerrado biome (a Savannah-like environment) but presents ecotones between the Caatinga and the Atlantic Forest (Figure 1). Sampling points varied in each municipality, covering urban, rural or sylvatic areas (Table 1). Free-living marmosets were captured using Tomahawk automatic traps and were examined as described elsewhere [9]. Sick or dead marmosets and howler monkeys collected through a previously established information network were also examined [10,11]. Serum and liver tissues samples were collected and frozen in liquid nitrogen (−196 °C) until the performance of serological and molecular assays. All protocols were previously approved by the Institutional Ethics Committee for Animal Experimentation (Protocol CEUA/IFNMG n° 14/2019) and by the Brazilian Ministry of the Environment (SISBIO n° 71714-2).

2.2. Plaque Reduction Neutralization Test (PRNT)

To assess the presence of OPXV-neutralizing antibodies, we used a plaque reduction neutralization test (PRNT), which is considered the gold standard for the differential diagnosis of OPXV antibodies. Such an assay has shown reliability, high specificity, and has been used in a number of seroprevalence studies that were designed to detect anti-OPXV neutralizing antibodies in different animal species [3,4,12]. The PRNT was performed as previously reported [13]. Essentially, serum was inactivated at 56 °C for 30 min and then diluted 1:20 in Eagle’s Minimum Essential Medium (MEM) (GIBCO®, Whaltam, USA) free of fetal bovine serum (FBS). The samples were mixed with an equal volume of a virus suspension containing approximately 150 plaque-forming units (PFU) of VACV strain Western Reserve. The solution was homogenized and incubated for 16 h at 37 °C, in a 5% CO2 atmosphere. Six-well plates containing BSC40 cells monolayers (CRL-2761, ATCC®, Manassas, USA) at 80% confluence were inoculated with virus/serum mix solutions and incubated at 37 °C for 1 h in 5% CO2 atmosphere. Subsequently, MEM with 2% FBS was added to each well and incubated for 2 days at 37 °C in a 5% CO2 atmosphere. When typical VACV-WR cytopathic effects were clearly observed, all monolayers were fixed with 3.7% formaldehyde and stained with 1% crystal violet (SYNTH®, Diadema, Brazil). Controls with infected and uninfected cells were included in each plate. To maintain the viability of the virus control, fetal bovine serum (FBS) was added to this solution at the same concentration (2.5%). The cell control contained 2.0% FBS media only. All samples were tested in triplicate. Aiming to guarantee high specificity, a serum sample was considered positive when an equal to or greater than 50% reduction in PFUs was detected, when compared to virus controls.

2.3. Real-Time PCR Assays

In order to improve the sensitivity and specificity of the real-time PCR serum, liver tissues were tested through two singleplex assays targeting two different OPXV genes: the C11R gene, related to the virus growth factor (VGF), a usually duplicated and conserved gene; and the A56R gene, which codes the viral hemagglutinin (HA) and is an important marker for molecular diagnostics. The primer sequences utilized were C11R F (5′ CGCTACAACAGATATTCCAGCTATCAG 3′), C11R R (5′ AGCGTGGATACAGTCACCGTGTAA 3′), A56 F (5′ CATCATCTGGAATTGTCACTACTAAA 3′), A56 R (5′ ACGGCCGACAATATAATTAATGC 3′) [3,14]. The two targets were tested in duplicate in a final volume of 10 μL in a StepOne® (Applied Biosystems, Foster City, USA) apparatus. The C11R and A56R genes were tested using SYBR® Green I Master Mix with the following settings: a cycle of DNA denaturation at 95 °C/20 min, 40 cycles of 95 °C/3 s and 60 °C/20 s, and a melting curve using 95 °C/3 s and 60 °C/20 s, followed by 4 °C increases in temperature up to 95 °C/15 s.

3. Results

The sampling efforts resulted in the collection of tissues from 63 neotropical primates belonging to three species (Callithrix penicillata and C. geoffroy—Callitrichidae family; and Alouatta caraya—Atelidae family), which were examined (Table 1, Figure 1). No skin lesions or other clinical signals were found in any of the animals examined. OPXV-specific neutralizing antibodies (more than 50% of neutralization) were detected in two (4.5%) of the 44 tested sera, both from C. penicillate (MG39 and MG45 samples, showing 55% and 85% PFU reduction, respectively), evidencing their previous exposure to the virus. Both individuals were sampled in urban areas (Table 1, Figure 1). Their sampling points were 505 km apart in a straight line. All real-time PCR assays in the search for OPXV genomes were negative.

4. Discussion

The close relationship between humans and other animals has been increasing due to the growth of the world population, as well as deforestation for food production and animal husbandry, making zoonoses increasingly frequent. These changes directly affect wildlife and bring humans ever closer to pathogens that, thus far, have only circulated in animals, and vice versa, increasing the risks of spillovers and spillbacks [15]. Furthermore, the increasing transport of live animals for trade (eventually involving legal and illegal wildlife specimens), industrialization processes, and global trade lead to an equally large increase in the potential for the emergence and spread of pathogens [16]. Therefore, it is estimated that more than 70% of human infections have a zoonotic origin [17].
The OPXV antibody-positive free-living neotropical primates detected in the current study demonstrate this scenario, since they were all captured in the urban environment, showing that they can live between forest environments and cities, potentially enabling spillover as well as spillback virus events [1,2,3,4]. Several viruses have been shown to be transmitted through such routes, including yellow fever virus and herpes viruses [18,19], even though little is known about several of them in circulation, as is the case with orthopoxviruses such as VACV, originally described in cows, in Brazil [20].
Recently, it has been shown that VACV persists not only in livestock, but also in wild reservoirs (including rodents and other mammals), as well as in equids, captive and domestic animals including cats and dogs [3,4,21]. In the Amazon biome, during a wildlife rescue for the construction of a hydroelectric plant, many wild animals were tested, and non-human primates of the genera Cebus and Alouatta (family—Cebidae and Atelidae, respectively) showed the highest detection rates of VACV. The animals were captured in a wild area and had no evidence of previous contact with humans and/or dairy cattle [3]. Here, despite a lower seropositivity rate, we demonstrated previous exposure to the OPXV of a new genus and family (Callithrix/Callitrichidae) of a neotropical primate living in close contact with humans. Genetics and ecological features could explain the difference that was found. Other studies outside the Amazon have demonstrated the participation of synanthropic and wild rodents or other mammals in the maintenance of the OPXV circulation [22]. An example of this is the VACV infections of domestic dogs and wild coatis (Nasua nasua) living in close contact in an overlapping area of urban and wild environments, suggesting a transmission cycle between domestic and wild animals [4,23]. Some rodent species can also function as intermediary hosts, acting as “bridges” between wild animals, domestic animals and humans [22,24]. In this study, samples were tested trough PRNT for serological screening because it is considered the gold standard, and due to the absence of specific reagents for the standardization of an ELISA test [12,25]. However, we are aware of the advantages that ELISA tests provide to serological studies, such as increasing specificity and the possibility of rapid execution [25,26].
Since all of the real-time PCR assays were negative and because serology can show any cross-reaction between different OPXVs, it is not possible to determine whether previous exposures were caused by VACV. However, VACV is the most widespread OPXV in Brazil and is endemic in Minas Gerais. Interestingly, this is the first time that evidence of VACV/OPXV exposition has been detected in C. penicillata, a species with a population of more than 10,000 individuals and that can live at the interface between cities and forests (ecotone), being commonly found in several Brazilian urban areas, in close contact with humans [27,28]. Furthermore, the geographic range of the two antibody-positive cases (505 km apart) suggests that this VACV/OPXV–Callithrix interaction is wide-ranging in the territory. Thus, studies on the circulation of OPXV in neotropical free-living primates are necessary, especially now, as monkeypox has been introduced to new regions of the planet, creating the possibility of establishing a zoonotic cycle through the occurrence of spillovers and spillbacks. An experimental pathogenesis study has, indeed, demonstrated that a neotropical primate (Callithrix jacchus—marmosets) can be infected by low doses of monkeypox virus and can produce a high viremia, as well as pathological signals that are consistent with monkeypox in humans [29]. Thus, VACV could pose a potential risk to public health in the same way as another virus (monkeypox) belonging to the same genus [6].

Author Contributions

Conceptualization, F.V.S.d.A., G.d.S.T. and D.B.d.O.; data curation, K.L.S.R., R.S.-O., M.V.M., T.G.M.S., M.E.G.-d.-S., S.M.A.-T., V.d.O.O. and A.J.J.d.S.; formal analysis, K.L.S.R., M.V.M., T.G.M.S., C.H.d.O., V.d.O.O., R.M.d.S., M.A.B.d.A. and D.B.d.O.; funding acquisition, B.M.R., F.S.C., A.C.F., P.M.R., G.d.S.T. and D.B.d.O.; investigation, F.V.S.d.A., R.S.-O., M.E.G.-d.-S., C.H.d.O., S.M.A.-T., E.d.S., J.d.C.C., A.A.S.C., G.R.A., A.d.P.S. and D.S.T.; methodology, M.V.M., T.G.M.S., C.H.d.O., V.d.O.O., A.J.J.d.S. and D.B.d.O.; project administration, F.S.C. and D.B.d.O.; resources, B.M.R. and P.M.R.; visualization, F.V.S.d.A., R.M.d.S. and A.T.-F.; writing—original draft, F.V.S.d.A., K.L.S.R., G.d.S.T. and D.B.d.O.; writing—review and editing, R.S.-O., M.V.M., T.G.M.S., M.E.G.-d.-S., C.H.d.O., S.M.A.-T., V.d.O.O., A.J.J.d.S., R.M.d.S., A.T.-F., M.A.B.d.A., E.d.S., J.d.C.C., A.A.S.C., G.R.A., A.d.P.S., B.M.R., D.S.T., F.S.C., A.C.F. and P.M.R. All authors have read and agreed to the published version of the manuscript.

Funding

Financial support was provided by the Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de Minas Gerais and Instituto Federal do Norte de Minas Gerais. A.C.F., B.M.R., F.S.C., G.d.S.T., G.R.A., and P.M.R. are researchers from Conselho Nacional de Desenvolvimento Científico e Tecnológico. G.d.S.T. is a researcher from CamaraPox/MCTI. P.M.R. was funded by CNPq grant n° 443215/2019-7. F.V.S.d.A. was funded by CNPq grant n° 401933/2020-2; IFNMG grant n° 21/2020 and Propape n° 245/2021; FAPEMIG grant n° APQ-01403-21. We also received support from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil (CAPES), Process 88882.348380/2010-1.

Institutional Review Board Statement

The animal study protocol was approved by the Institutional Ethics Committee for Animal Experimentation of Instituto Federal do Norte de Minas (Protocol CEUA/IFNMG n° 14/2019) and by the Brazilian Ministry of the Environment (SISBIO n° 71714-2).

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors thank Pedro Augusto Souza for his valuable contribution to the field work. We are also grateful to members of Secretaria de Saúde and Centro de Controle de Zoonoses of Salinas, Berizal, Rubelita, Coronel Murta, Unaí, Arinos, Rio Pardo de Minas, Taiobeiras, Icaraí de Minas, Ubaí, Brasília de Minas and Januária for their support during the field expeditions.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kroon, E.G.; Mota, B.E.F.; Abrahão, J.S.; da Fonseca, F.G.; Trindade, G.D.S. Zoonotic Brazilian Vaccinia virus: From field to therapy. Antivir. Res. 2011, 92, 150–163. [Google Scholar] [CrossRef] [PubMed]
  2. de Oliveira, J.S.; Figueiredo, P.D.O.; Costa, G.B.; de Assis, F.L.; Drumond, B.P.; Da Fonseca, F.G.; Nogueira, M.L.; Kroon, E.G.; Trindade, G.D.S. Vaccinia virus natural infections in Brazil: The good, the bad, and the ugly. Viruses 2017, 9, 340. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Abrahão, J.S.; Silva-Fernandes, A.T.; Lima, L.S.; Campos, R.K.; Guedes, M.I.; Cota, M.M.; Assis, F.L.; Borges, I.A.; Souza-Júnior, M.F.; Lobato, Z.I.; et al. Vaccinia virus infection in monkeys, Brazilian Amazon. Emerg. Infect. Dis. 2010, 16, 976–979. [Google Scholar] [CrossRef]
  4. Costa, G.B.; De Almeida, L.R.; Cerqueira, A.G.R.; Mesquita, W.U.; De Oliveira, J.S.; Miranda, J.B.; Saraiva-Silva, A.T.; Abrahão, J.S.; Drumond, B.P.; Kroon, E.G.; et al. Vaccinia virus among domestic dogs and wild coatis, Brazil, 2013–2015. Emerg. Infect. Dis. 2018, 24, 2338–2342. [Google Scholar] [CrossRef] [PubMed]
  5. Bunge, E.M.; Hoet, B.; Chen, L.; Lienert, F.; Weidenthaler, H.; Baer, L.R.; Steffen, R. The changing epidemiology of human mon-keypox—A potential threat? A systematic review. PLoS Negl. Trop. Dis. 2022, 16, e0010141. [Google Scholar] [CrossRef] [PubMed]
  6. WHO. Multi-Country Monkeypox Outbreak in Non-Endemic Countries. 2022. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385 (accessed on 17 June 2022).
  7. Leite, J.A.; Drumond, B.P.; Trindade, G.S.; Lobato, Z.I.P.; Da Fonseca, F.G.; Dos Santos, J.R.; Madureira, M.C.; Guedes, M.I.M.C.; Ferreira, J.M.S.; Bonjardim, C.A.; et al. Passatempo virus, a vaccinia virus strain, Brazil. Emerg. Infect. Dis. 2005, 11, 1935. [Google Scholar] [CrossRef]
  8. Trindade, G.S.; Lobato, Z.I.P.; Drumond, B.P.; Leite, J.A.; Trigueiro, R.C.; Guedes, M.I.M.C.; Da Fonseca, F.G.; dos Santos, J.R.; Bonjardim, C.A.; Ferreira, P.C.P.; et al. Short report: Isolation of two Vaccinia virus strains from a single bovine vaccinia outbreak in rural area from Brazil: Implications on the emergence of zo-onotic orthopoxviruses. Am. J. Trop. Med. Hyg. 2006, 75, 486–490. [Google Scholar] [CrossRef] [PubMed]
  9. de Abreu, F.V.S.; Ferreira-De-Brito, A.; Azevedo, A.D.S.; Linhares, J.H.R.; Santos, V.D.O.; Miranda, E.H.; Neves, M.S.A.S.; Yousfi, L.; Ribeiro, I.P.; dos Santos, A.A.C.; et al. Survey on Non-Human Primates and Mosquitoes Does not Provide Evidences of Spillover/Spillback between the Urban and Sylvatic Cycles of Yellow Fever and Zika Viruses Following Severe Outbreaks in Southeast Brazil. Viruses 2020, 12, 364. [Google Scholar] [CrossRef] [Green Version]
  10. Abreu, F.V.S.; dos Santos, E.; Gomes, M.Q.; Vargas, W.P.; Oliveira Passos, P.H.; Nunes e Silva, C.; Araújo, P.C.; Pires, J.R.; Romano, A.P.M.; Teixeira, D.S.; et al. Capture of Alouatta guariba clamitans for the surveillance of sylvatic yellow fever and zoonotic malaria: Which is the best strategy in the tropical Atlantic Forest? Am. J. Primatol. 2019, 81, e23000. [Google Scholar] [CrossRef]
  11. Andrade, M.S.; Campos, F.S.; Oliveira, C.H.; de Oliveira, R.S.; Campos, A.A.S.; Almeida, M.A.B.; Simonini-Teixeira, D.; da Sevá, A.P.; Temponi, A.O.D.; Magalhães, F.M.; et al. Fast surveillance response and genome sequencing reveal the circulation of a new Yellow Fever Virus sublineage in 2021, in Minas Gerais, Brazil. bioRxiv. 2021, 469129. [Google Scholar] [CrossRef]
  12. Kroon, G.E.; Santos Abrahão, J.; de Souza Trindade, G.; Pereira Oliveira, G.; Moreira Franco Luiz, A.P.; Barbosa Costa, G.; Lima, M.T.; Calixto, R.S.; de Oliveira, D.B.; Drumond, B.P. Natural vaccinia virus infection: Diagnosis, isolation, and characterization. Curr. Protoc. Microbiol. 2016, 42, 14A. 5.1–14A. 5.43. [Google Scholar] [CrossRef]
  13. Newman, F.K.; Frey, S.E.; Blevins, T.P.; Mandava, M.; Bonifacio, A., Jr.; Yan, L.; Belshe, R.B. Improved assay to detect neu-tralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. J. Clin. Microbiol. 2003, 41, 3154–3157. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Trindade, G.S.; Emerson, G.L.; Carroll, D.S.; Kroon, E.; Damon, I.K. Brazilian vaccinia viruses and their origins. Emerg. Infect. Dis. 2007, 13, 965–972. [Google Scholar] [CrossRef] [PubMed]
  15. Jenkins, E.; Simon, A.; Bachand, N.; Stephen, C. Wildlife parasites in a One Health world. Trends Parasitol. 2015, 31, 174–180. [Google Scholar] [CrossRef] [PubMed]
  16. Green, S. The Bioeconomics of Domesticating Zoonoses. Cult. Anthr. 2022, 37, 30–36. [Google Scholar] [CrossRef]
  17. Jones, K.E.; Patel, N.G.; Levy, M.A.; Storeygard, A.; Balk, D.; Gittleman, J.L.; Daszak, P. Global trends in emerging infectious diseases. Nature 2008, 451, 990–993. [Google Scholar] [CrossRef]
  18. Longa, C.S.; Bruno, S.F.; Pires, A.R.; Romijn, P.C.; Kimura, L.S.; Costa, C.H.C. Human Herpesvirus 1 in wild marmosets, Brazil, 2008. Emerg. Infect. Dis. 2011, 17, 1308–1310. [Google Scholar] [CrossRef]
  19. Mares-Guia, M.A.M.D.M.; Horta, M.A.; Romano, A.; Rodrigues, C.D.S.; Mendonça, M.C.L.; Dos Santos, C.C.; Torres, M.C.; Araujo, E.S.M.; Fabri, A.; De Souza, E.R.; et al. Yellow fever epizootics in non-human primates, Southeast and Northeast Brazil (2017 and 2018). Parasites Vectors 2020, 13, 90. [Google Scholar] [CrossRef]
  20. Domingos, J.S.I.; Silva de Oliveira, J.; Rocha, L.S.R.K.; Oliveira, D.B.; Kroon, G.E.; Barbosa, G.C.; Trindade, G.S. Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going? Pathogens 2021, 10, 406. [Google Scholar] [CrossRef]
  21. Peres, M.G.; Bacchiega, T.S.; Appolinário, C.M.; Vicente, A.F.; Allendorf, S.D.; Antunes, J.M.A.P.; Moreira, S.A.; Legatti, E.; Fonseca, C.R.; Pituco, E.M.; et al. Serological study of vaccinia virus reservoirs in areas with and without official reports of outbreaks in cattle and humans in São Paulo, Brazil. Arch. Virol. 2013, 158, 2433–2441. [Google Scholar] [CrossRef]
  22. Abrahão, J.S.; Guedes, M.I.; Trindade, G.S.; Fonseca, F.G.; Campos, R.K.; Mota, B.F.; Lobato, Z.I.P.; Silva-Fernandes, A.T.; Rodrigues, G.O.L.; Lima, L.S.; et al. One more piece in the VACV ecological puzzle: Could peridomestic rodents be the link between wildlife and bovine vaccinia outbreaks in Brazil? PLoS ONE 2009, 4, 7428. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Peres, M.G.; Bacchiega, T.S.; Appolinário, C.M.; Vicente, A.F.; Mioni, M.S.R.; Ribeiro, B.L.D.; Fonseca, C.R.S.; Pelícia, V.C.; Ferreira, F.; Abrahão, J.S.; et al. Vaccinia virus in feces and urine of wild rodents from São Paulo State, Brazil. Viruses 2018, 10, 51. [Google Scholar] [CrossRef] [Green Version]
  24. Miranda, J.B.; Borges, I.A.; Campos, S.P.S.; Vieira, F.N.; De Ázara, T.M.F.; Marques, F.A.; Costa, G.B.; Luis, A.P.M.F.; De Oliveira, J.S.; Ferreira, P.C.P.; et al. Serologic and molecular evidence of vaccinia virus circulation among small mammals from different biomes, Brazil. Emerg. Infect. Dis. 2017, 23, 931–938. [Google Scholar] [CrossRef] [PubMed]
  25. Cohen, B.; Doblas, D.; Andrews, N. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination. Vaccine 2008, 26, 6392–6397. [Google Scholar] [CrossRef]
  26. Gallardo-Romero, N.F.; Arechiga-Ceballos, N.; Emerson, G.L.; Martínez-Martínez, F.O.; Doty, J.B.; Nakazawa, Y.J.; Rendón-Franco, E.; Muñoz-García, C.I.; Villanueva-García, C.; Ramírez-Cid, C.; et al. Endemic Orthopoxvirus circulating in procyonids in Mexico. J. Wildl. Dis. 2016, 52, 609–615. [Google Scholar] [CrossRef]
  27. Teixeira, B.; Hirsch, A.; Goulart, V.D.L.R.; Passos, L.P.; Teixeira, C.P.; James, P.; Young, R.J. Good neighbours: Distribution of black-tufted marmoset (Callithrix penicillata) in an urban environment. Wildl. Res. 2015, 42, 579–589. [Google Scholar] [CrossRef]
  28. Bicca-Marques, J.; Jerusalinsky, L.; Mittermeier, R.A.; Pereira, D.; Ruiz-Miranda, C.; Rímoli, J.; Valença Montenegro, M.; do Valle, R.R. Callithrix penicillata. The IUCN Red List of Threatened Species 2018: E. T41519A1793579, 2018.
  29. Mucker, E.M.; Chapman, J.; Huzella, L.M.; Huggins, J.W.; Shamblin, J.; Robinson, C.G.; Hensley, L.E. Susceptibility of mar-mosets (Callithrix jacchus) to monkeypox virus: A low dose prospective model for monkeypox and smallpox disease. PLoS ONE 2015, 10, e0131742. [Google Scholar] [CrossRef]
Figure 1. Map showing sampling points and biomes of Minas Gerais, Brazil. The two sera where OPXV-specific neutralizing antibodies were detected are shown with red dots. Satellite images show points of collection of OPXV antibody-positive NHPs in the urban areas of Unaí (left) and Coronel Murta (right). The figure was created using QGIS software version 3.10 and Google Earth.
Figure 1. Map showing sampling points and biomes of Minas Gerais, Brazil. The two sera where OPXV-specific neutralizing antibodies were detected are shown with red dots. Satellite images show points of collection of OPXV antibody-positive NHPs in the urban areas of Unaí (left) and Coronel Murta (right). The figure was created using QGIS software version 3.10 and Google Earth.
Pathogens 11 01167 g001
Table 1. Description of samples tested by species, habitat, date of collection, sampling point, tissue and city. Sera were tested through PRNT and real-time PCR. Liver tissues were tested through real-time PCR. OPXV antibody-positive samples are highlighted. Legend: neg = negative; PRNT-pos = positive in the PRNT assays; “−” = tissue not available.
Table 1. Description of samples tested by species, habitat, date of collection, sampling point, tissue and city. Sera were tested through PRNT and real-time PCR. Liver tissues were tested through real-time PCR. OPXV antibody-positive samples are highlighted. Legend: neg = negative; PRNT-pos = positive in the PRNT assays; “−” = tissue not available.
IDSpeciesHabitatCollection DateLatitudeLongitudeSerumLiverCity
MG10C. penicillataSylvatic04/07/2020−16.120847−42.209519negSalinas
MG11C. penicillataSylvatic04/07/2020−16.120847−42.209519neg
MG12C. penicillataSylvatic04/07/2020−16.120847−42.209519neg
MG13C. penicillataSylvatic04/07/2020−16.120847−42.209519neg
MG25C. penicillataUrban19/09/2020−16.160950−42.293317neg
MG26C. penicillataUrban21/09/2020−16.160950−42.293317neg
MG62C. penicillataSylvatic13/04/2021−16.026000−42.266000neg
MG63C. penicillataRural13/04/2021−16.157528−42.311306neg
MG70C. penicillataRural10/09/2021−16.157528−42.311306neg
MG64C. penicillataRural24/07/2021−16.157528−42.311306neg
MG96C. penicillataRural17/02/2022−16.15637−42.30730neg
MG14C. penicillataRural30/07/2020−15.711878−41.800169negBerizal
MG15C. penicillataRural30/07/2020−15.711878−41.800169neg
MG32C. geoffroyiRural18/10/2020−16.12522−42.159269negAraçuaí
MG33C. penicillataRural19/10/2020−16.553161−42.176839negCoronel Murta
MG34C. penicillataRural19/10/2020−16.553161−42.176839neg
MG35C. penicillataRural20/10/2020−16.553161−42.176839neg
MG36C. penicillataRural20/10/2020−16.553161−42.176839neg
MG38C. penicillataRural20/10/2020−16.553161−42.176839neg
MG39C. penicillataUrban21/10/2020−16.619644−42.183942PRNT-POS
MG43C. penicillataUrban11/01/2021−16.352694−46.881139negUnaí
MG45C. penicillataUrban11/01/2021−16.352694−46.881139PRNT-POS
MG46C. penicillataUrban11/01/2021−16.352694−46.881139neg
MG48A. carayaRural17/01/2021−16.308444−46.907722neg
MG49A. carayaRural17/01/2021−16.308445−46.907723neg
MG50C. penicillataRural19/01/2021−15.911472−46.099972negArinos
MG51C. penicillataRural19/01/2021−15.848770−46.300809neg
MG52C. penicillataUrban20/03/2021−15.609222−42.542694negRio Pardo de Minas
MG53C. penicillataUrban20/03/2021−15.609222−42.542694neg
MG54C. penicillataRural20/03/2021−15.629972−42.508472neg
MG55C. penicillataRural20/03/2021−15.629972−42.508472neg
MG56C. penicillataUrban22/03/2021−15.807389−42.239111negTaiobeiras
MG57C. penicillataUrban22/03/2021−15.807389−42.239111neg
MG58C. penicillataRural23/03/2021−15.817889−42.159972neg
MG59C. penicillataRural23/03/2021−15.817889−42.159972neg
MG60C. penicillataSylvatic24/03/2021−15.841139−42.229750neg
MG61C. penicillataSylvatic24/03/2021−15.841139−42.229750neg
MG66A. carayaSylvatic25/08/2021−16.217389−44.783694negIcaraí de Minas
MG72A. carayaSylvatic13/09/202116.340278−44.947139neg
MG73A. carayaSylvatic13/09/2021−16.356083−44.965333neg
MG74A. carayaSylvatic13/09/2021−16.356083−44.965333neg
MG68C. penicillataRural26/08/2021−16.311667−44.810000negUbaí
MG76A. carayaSylvatic16/09/2021−16.385444−44.947083neg
MG78C. penicillataRural17/01/2022−15.44731−44.37050negJanuária
MG79C. penicillataRural17/01/2022−15.44731−44.37050neg
MG90C. penicillataRural20/01/2022−15.44731−44.37050neg
MG91C. penicillataRural23/01/2022−15.44731−44.37050neg
MG75C. penicillataRural14/09/2021−16.354417−44.349639negBrasília de Minas
MG77A. carayaSylvatic20/11/2021−16.32207−44.42859neg
MG80A. carayaSylvatic18/01/2022−16.309691−44.382729neg
MG81A. carayaSylvatic18/01/2022−16.309644−44.382161neg
MG82A. carayaSylvatic17/01/2022−16.309691−44.382729neg
MG83A. carayaSylvatic17/01/2022−16.309691−44.382729neg
MG84A. carayaSylvatic17/01/2022−16.309694−44.382709neg
MG85A. carayaSylvatic17/01/2022−16.309664−44.382386neg
MG86C. penicillataRural18/01/2022−16.30962−44.38238neg
MG87C. penicillataRural18/01/2022−16.30962−44.38238neg
MG88C. penicillataRural18/01/2022−16.30962−44.38238neg
MG89A. carayaSylvatic19/01/2022−16.306517−44.383528neg
MG92C. penicillataSylvatic25/02/2022−15.348677−44.900128negBonito de Minas
MG93C. penicillataSylvatic25/02/2022−15.348677−44.900128neg
MG94C. penicillataRural29/01/2022−15.346668−44.676110neg
MG95C. penicillataRural29/01/2022−15.346668−44.676110neg
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Abreu, F.V.S.d.; Lorene Soares Rocha, K.; Silva-Oliveira, R.; Macedo, M.V.; Silva, T.G.M.; Gonçalves-dos-Santos, M.E.; de Oliveira, C.H.; Aquino-Teixeira, S.M.; Ottone, V.d.O.; da Silva, A.J.J.; et al. Serological Evidence of Orthopoxvirus Infection in Neotropical Primates in Brazil. Pathogens 2022, 11, 1167. https://doi.org/10.3390/pathogens11101167

AMA Style

Abreu FVSd, Lorene Soares Rocha K, Silva-Oliveira R, Macedo MV, Silva TGM, Gonçalves-dos-Santos ME, de Oliveira CH, Aquino-Teixeira SM, Ottone VdO, da Silva AJJ, et al. Serological Evidence of Orthopoxvirus Infection in Neotropical Primates in Brazil. Pathogens. 2022; 11(10):1167. https://doi.org/10.3390/pathogens11101167

Chicago/Turabian Style

Abreu, Filipe Vieira Santos de, Kamila Lorene Soares Rocha, Ramon Silva-Oliveira, Mariana Viana Macedo, Thamires Gabriele Macedo Silva, Maria Eduarda Gonçalves-dos-Santos, Cirilo Henrique de Oliveira, Sandy Micaele Aquino-Teixeira, Vinícius de Oliveira Ottone, Alex Junio Jardim da Silva, and et al. 2022. "Serological Evidence of Orthopoxvirus Infection in Neotropical Primates in Brazil" Pathogens 11, no. 10: 1167. https://doi.org/10.3390/pathogens11101167

APA Style

Abreu, F. V. S. d., Lorene Soares Rocha, K., Silva-Oliveira, R., Macedo, M. V., Silva, T. G. M., Gonçalves-dos-Santos, M. E., de Oliveira, C. H., Aquino-Teixeira, S. M., Ottone, V. d. O., da Silva, A. J. J., dos Santos, R. M., Tátila-Ferreira, A., Almeida, M. A. B. d., dos Santos, E., da Cruz Cardoso, J., Campos, A. A. S., Albuquerque, G. R., da Paixão Sevá, A., Ribeiro, B. M., ... Bretas de Oliveira, D. (2022). Serological Evidence of Orthopoxvirus Infection in Neotropical Primates in Brazil. Pathogens, 11(10), 1167. https://doi.org/10.3390/pathogens11101167

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop